Differential protein expression profiling by ITRAQ-2DLC-MS/MS of human bladder cancer EJ138 cells transfected with the metastasis suppressor kiss-1 gene by Ruppen, Isabel et al.
P. 1
Posters Posters  •  S1. Quantitative Proteomics
61
DIFFERENTIAL PROTEIN EXPRESSION PROFILING 
BY ITRAQ-2DLC-MS/MS OF HUMAN BLADDER 
CANCER EJ138 CELLS TRANSFECTED WITH 
THE METASTASIS SUPPRESSOR KISS-1 GENE
Isabel Ruppen1, Laura Grau2, Marta Gil2, Keith Ashman1 
and Marta Sánchez-Carbayo2
1Unidad de Proteómica; 2Grupo de Marcadores tumorales 
Centro Nacional de Investigaciones Oncológicas, E-28029 Madrid, Spain
The use of isobaric tags for relative and absolute quantization (iTRAQ) followed 
by multidimensional liquid chromatography (LC) and tandem mass spectrometry (MS/
MS) analysis is emerging as a powerful methodology for biomarker and drug target 
discovery. KiSS-1 is a metastasis suppressor gene that has been reported to be involved 
in the progression of several solid neoplasias. The loss of KiSS-1 gene expression has 
been shown to be inversely correlated with increasing tumour stage and poor overall 
survival in bladder tumors. Moreover, cases developing distant metastases displayed 
complete loss of KiSS-1 expression. In order to identify the molecular pathways 
associated with the metastasis suppressor role of KiSS-1 in bladder cancer, we carried 
out a proteome discovery analysis of bladder cancer cells (EJ138) transiently transfected 
with a vector encompassing the full length KiSS-1 gene using an iTRAQ approach. 
Protein extracts collected after 24h and 48h transfection were fractionated, digested with 
trypsin and treated with iTRAQ reagents. The labelled peptides were separated through 
Strong Cation Exchange (SCX) and Reversed Phase LC and analysed by MALDI TOF/
TOF MS. Three software packages were utilized for data analysis: ProteinPilot for 
identification and quantification of differentially expressed proteins, Protein Center for 
gene ontology (GO) analysis and Ingenuity Pathway to provide insight into biological 
networks. Comparative analysis among transfected, mock and empty vector exposed 
cells have identified more than 800 proteins with high confidence (>99%), showing high 
correlation rates among replicates (>70%). The involvement of the identified proteins 
in biological networks has served to characterize molecular pathways associated with 
KiSS-1 expression and to select critical candidates for validation analyses by Western 
Blot using independent transfected replicates. As part of complementary clinical 
validation strategies, inmunohistochemical analyses of potential metastasis-related 
biomarkers in bladder cancer progression have been performed in metastatic bladder 
tumours spotted onto tissue microarrays (n=78). In summary, our study not only has 
served to reveal molecular mechanisms associated with the metastasis suppressor role 
of KiSS-1 in bladder cancer, but also to identify novel potential metastatic biomarkers 
for patients affected with bladder tumors.
